Telehealth

CloudMD to Report Second Quarter Financial Results on Monday, August 22, 2022

Retrieved on: 
Thursday, August 18, 2022 - 9:48pm
Digital Solutions, GLOBE, Center for Pan Asian Community Services, Inc., Student, Technology, Ecosystem, Telehealth, Conference call, Nursing, Company, Mission statement, Pharmacy, Artificial intelligence, Financial statement, MD, Conference, Health, OTCQX, Medicine

VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (CloudMD or the Company), a healthcare technology and innovative health services company transforming the delivery of care, announced today that the Company will release its financial results for the second quarter of 2022 on Monday, August 22, 2022 after market close.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (CloudMD or the Company), a healthcare technology and innovative health services company transforming the delivery of care, announced today that the Company will release its financial results for the second quarter of 2022 on Monday, August 22, 2022 after market close.
  • CloudMD will hold its Q2 2022 earnings conference call and webinar on Tuesday, August 23, 2022 at 9:00am ET (6:00am PT).
  • Conference call and webinar details:
    A link to the live event, as well as the financial statements and MD&A will be available on the Financial Statements page of the Companys website .
  • CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care.

Favor Teams Up with imaware to Offer Discrete At-Home STI Tests to Women and People Who Menstruate

Retrieved on: 
Thursday, August 18, 2022 - 2:00pm
Woman, Reproductive health, MG, Biomarker, Chlamydia, CEO, GLOBE, Simplex, College, Syphilis, Technology, Telehealth, Prevalence, STI, Congenital syphilis, American Journal, Patient, CDC, COVID-19, Ureaplasma urealyticum, Gonorrhea, Preventive healthcare, Men's Health, Coronavirus, CAP, HIPAA, Mycoplasma genitalium, Clinical Laboratory Improvement Amendments, Trichomoniasis, American Journal of Preventive Medicine, Insurance, Digital, Solution, Degenerative disease, CLIA, Health, Birth control, Pharmaceutical industry

“Favor deeply understands women’s health and how unique each patient’s journey can be. STI testing is more than just a box and what’s inside; it’s critical to understand the worries and challenges that patients face when they go to get tested -- from cost of testing to sensitivities around discretion,” said Jani Tuomi, founder of imaware. “imaware was created to make scientifically validated tools for screening and monitoring health more accessible and convenient and we are extremely proud to be partnering with Favor, a company closely aligned with our own mission.”

Key Points: 
  • This custom, one-of-a-kind test kit goes beyond existing at-home STI tests on the market to provide women and people who menstruate with a more comprehensive and accurate picture of their reproductive health.
  • The STI test, and customer experience, leverages advanced capabilities of imaware, a leader in testing technology and digital health.
  • As an antidote to the screening gap, imaware has developed its first at-home STI test that is accessible, convenient and accurate.
  • Favor is the nations leading integrated digital healthcare platform on a mission to empower women and people who menstruate to lead their healthiest lives.

Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds

Retrieved on: 
Thursday, August 18, 2022 - 12:00pm
Public Policy, Government, Insurance, White House, Federal Government, Health, Mental Health, Healthcare Reform, Professional Services, Health Insurance, Loneliness, Medicare Advantage, Telehealth, Fortis Healthcare, Intelligence, Industry, Medicare, Mental health, Social isolation, Prevalence, Technology, J.D. Power, Communication, American Journal, Patient, Kaiser Permanente, COVID-19, American Journal of Preventive Medicine, Artificial intelligence, SM, Commonwealth Fund, Consumer, Medicare Part D coverage gap, Mental, Big data, Speech disorder, Improvement, Health, Preventive healthcare, Health insurance, Retail, Pharmaceutical industry, Humana, Highmark

Power 2022 U.S. Medicare Advantage Study,SM released today, some concerning trends are brewing beneath the surface of those positive headline numbers.

Key Points: 
  • Power 2022 U.S. Medicare Advantage Study,SM released today, some concerning trends are brewing beneath the surface of those positive headline numbers.
  • Most notably, a majority of Medicare Advantage plan members are saying they do not have enough coverage for mental health and substance use disorder services.
  • Missing the mark on mental health and substance abuse disorder services: Just 38% of Medicare Advantage plan members say they have enough coverage for mental health treatment, down from 39% a year ago.
  • The 2022 Medicare Advantage Study is based on the responses of 3,094 members of Medicare Advantage plans across the United States.

MedWand™ Solutions, Inc. is Transforming Telemedicine with Award-Winning Device and VirtualCare Platform, Now Available

Retrieved on: 
Wednesday, August 17, 2022 - 7:41pm
Practice Management, Technology, FDA, Managed Care, Health, Health Technology, Medical Devices, Software, Artificial Intelligence, Telemedicine, Virtual Medicine, Hardware, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Multimedia, Ecosystem, Telehealth, Hospital, EMR, Spirometry, Practice management software, US FDA, Health equity, Health, Patient, Solution, Temperature, Nursing, School, Data analysis, Pharynx, Ultra, Electronic health record, Blood pressure, Physician, Lung, US, Software, Heart, MD, Internet access, Food, Entrepreneurship, Medical imaging, Medical device

MedWand Solutions, Inc. is pleased to announce that the company's groundbreaking MedWand device and VirtualCare ecosystem is commercially available to enable clinical exams with its comprehensive care solutions.

Key Points: 
  • MedWand Solutions, Inc. is pleased to announce that the company's groundbreaking MedWand device and VirtualCare ecosystem is commercially available to enable clinical exams with its comprehensive care solutions.
  • Poised to transform the current capabilities of telemedicine, MedWand is offering various kits including: the MedWand Evaluation Kit, the MedWand Mobile Clinic, and the MedWand Remote Clinic.
  • View the full release here: https://www.businesswire.com/news/home/20220817005666/en/
    Transforming the current understanding of telemedicine, MedWand combines multiple clinically accurate vitals sensors and an Ultra-HD resolution camera into one, handheld, lightweight device.
  • Transforming the current understanding of telemedicine, MedWand combines multiple clinically accurate vitals sensors and an Ultra-HD resolution camera into one, handheld, lightweight device.

Onduo by Verily and Sword Health partner to accelerate adoption of comprehensive, precision care approach

Retrieved on: 
Wednesday, August 17, 2022 - 5:14pm
Mental Health, Human Resources, Diabetes, Fitness & Nutrition, Professional Services, Cardiology, Other Health, Physical Therapy, General Health, Health, Newton, FDA, Movement, Sword, Mental health, Population, Technology, European Journal, Physical therapy, Prevalence, LLC, MSK, Pain, European Journal of General Practice, Quality of life, Mark (given name), Data science, Program, Health, Family medicine, Accreditation, Therapy, Google, Â, Blood pressure, Anxiety, Diabetes, Hypertension, Digital, Verily, Lists of diseases, Solution, Weight loss, Organization, Pharmaceutical industry, Medicine, Telehealth

Onduo by Verily, an Alphabet precision health company, announced today a strategic collaboration with Sword Health, the fastest-growing digital musculoskeletal (MSK) care provider, to offer complementary solutions to each companys employer customers and their employees.

Key Points: 
  • Onduo by Verily, an Alphabet precision health company, announced today a strategic collaboration with Sword Health, the fastest-growing digital musculoskeletal (MSK) care provider, to offer complementary solutions to each companys employer customers and their employees.
  • Guided by evidence-based medical care and informed by data, Onduo helps employers and health plans deliver precision health at scale.
  • Onduo provides a whole-person care solution featuring digital, connected care with a human touch for diabetes, hypertension, weight loss and diabetes prevention.
  • Onduo LLC and a network of affiliated professional entities (collectively, Onduo) collaborate to offer certain care management and coordinated clinical care programs.

Telehealth Market Worth $539.73 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, August 17, 2022 - 3:00pm
Cloud, Well, Movement, Cardiology, Dermatology, Telehealth, Intelligence, Peripheral, Technology, Growth, Telecommunication, Radiology, ICU, Confidentiality, Hospital, Prevalence, ECG, Government, Patient, CDC, Telepsychiatry, COVID-19, Cerner, Conditional sentence, Awareness, Cisco Systems, Geography, CAGR, Research, Lists of countries and territories, Privacy, Physician, Component, RMON, Impact, Efficiency, Adoption, Healthcare, Pharmaceutical industry, Medical imaging, Software, Psychiatry

Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.

Key Points: 
  • Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.
  • Based on application, the telehealth market is segmented into psychiatry, radiology, cardiology, primary care, dermatology, remote ICU, and other applications.
  • Quick Buy Telehealth Market Research Report: https://www.meticulousresearch.com/Checkout/33290201
    Based on end user, the healthcare providers segment is estimated to account for the largest share of the market in 2022.
  • The telehealth market has witnessed several new product launches, approvals, partnerships & agreements, and acquisitions in recent years.

Telehealth Market Worth $539.73 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, August 17, 2022 - 3:00pm
Cloud, Well, Movement, Cardiology, Dermatology, Telehealth, Intelligence, Peripheral, Technology, Growth, Telecommunication, Radiology, ICU, Confidentiality, Hospital, Prevalence, ECG, Government, Patient, CDC, Telepsychiatry, COVID-19, Cerner, Conditional sentence, Awareness, Cisco Systems, Geography, CAGR, Research, Lists of countries and territories, Privacy, Physician, Component, RMON, Impact, Efficiency, Adoption, Healthcare, Pharmaceutical industry, Medical imaging, Software, Psychiatry

Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.

Key Points: 
  • Similarly, reluctance to migrate from traditional systems, chances ofmisdiagnosis, and technological barriers in developing countries may pose challenges to market players.
  • Based on application, the telehealth market is segmented into psychiatry, radiology, cardiology, primary care, dermatology, remote ICU, and other applications.
  • Quick Buy Telehealth Market Research Report: https://www.meticulousresearch.com/Checkout/33290201
    Based on end user, the healthcare providers segment is estimated to account for the largest share of the market in 2022.
  • The telehealth market has witnessed several new product launches, approvals, partnerships & agreements, and acquisitions in recent years.

Nuvo Group and Sheba Medical Center's "Sheba BEYOND" Complete First Phase of Collaboration to Create a Virtual Obstetric Solution & Catalyze Research to Advance the Standard of Pregnancy Care

Retrieved on: 
Wednesday, August 17, 2022 - 1:00pm
FDA, Woman, Multimedia, Fast Company, Industry, CEO, Tel HaShomer, Technology, Pregnancy, Telehealth, CB Insights, Obstetrics, Top Ten, Research, Health, Sheba Medical Center, Gestational diabetes, Patient, Academic health science centre, TEL, View, Program, Parent, Partnership, Tuba City Regional Health Care Corporation, Nuvo, Thought, Physician, Goal, NEWSWEEK, Digital, Solution, Mother, Heart, Medicine, Contraindication, City, INVU, Medical device, Online shopping

TEL AVIV, Israel, Aug. 17, 2022 /PRNewswire/ -- Nuvo Group—the creators of INVU by Nuvo™, an FDA-approved remote pregnancy monitoring platform—announced today that it has completed the first phase of its collaboration agreement with Israel's Sheba Medical Center's "Sheba BEYOND", one of the Top Ten medical centers in the world (NEWSWEEK) and a global leader in biotechnological innovation.

Key Points: 
  • Participating physicians prescribed INVU to expectant mothers, who wore the sensor band from home during virtual visits.
  • For the next phase of the partnership, Nuvo and Sheba intend to work together to integrate the INVU platform into the hospital's standard of care protocols.
  • The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation.
  • Sheba BEYOND is the medical center's innovative virtual hospital, which offers a myriad of technological solutions for advanced patient care.

CloudMD Provides Business Update on Customer Momentum

Retrieved on: 
Wednesday, August 17, 2022 - 12:30pm
Digital Solutions, Industry, Technology, Growth, Ecosystem, Telehealth, United States Public Health Service, MHSS, Nursing, Company, Pharmacy, Program, Toronto Coach Terminal, Ontario government debt, ARR, Artificial intelligence, Government, Time, Student, Health, Pharmaceutical industry, Medicine

CloudMD has already implemented several of these initiatives and will continue to take the necessary steps to right-size its cost structure related to the program accordingly.

Key Points: 
  • CloudMD has already implemented several of these initiatives and will continue to take the necessary steps to right-size its cost structure related to the program accordingly.
  • CloudMD continues to engage in discussions with the Ontario Government on how to continue to expand access to mental health services for all Ontarians.
  • CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care.
  • CloudMDs business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Companys fastest growing division.

INDRC Conference 2022: “Artificial Intelligence Solutions for Understanding and Treatment of Neurodegenerative Disorders” Launched by International Neurodegenerative Disorders Research Center in Prague, Czech Republic

Retrieved on: 
Wednesday, August 17, 2022 - 11:00am
Research, General Health, Biometrics, Technology, Artificial Intelligence, Genetics, Clinical Trials, Science, Biotechnology, Neurology, Other Science, Health, Public health, Total Intelligence Solutions, Dementia, Algorithm, Brain, Telehealth, Knowledge, Research, Communication, Method, Patient, Neurodegeneration, Lists of diseases, Parliament of the Czech Republic, Biology, University, Biochemistry, MD, Disease, ML, Machine learning, Union, Neuron, Technology, Protein engineering, Public, Environment, Mathematics, Knowledge management, Neuroscience, Doctor of Philosophy, Science, Conference, Intelligence, Lord, Czech Presidency of the Council of the European Union, 2009, Directorate for EU Affairs, Artificial intelligence, AD, Neurological disorder, Solution, Parliament, AI, Alzheon, Senate, Institute, Biomedical Research, Santa Clara City Library, Biophysics, Treatment, Council, Medicine, Saint Anthony Falls Laboratory, Medical device, Pharmaceutical industry, Health

INDRC, International Neurodegenerative Disorders Research Center , a private, non-profit, global research institute established to apply artificial intelligence (AI) and machine learning (ML) solutions to identify and validate therapeutic interventions for Alzheimers disease (AD) and other neurodegenerative disorders, today announced the launch of the INDRC Conference 2022: Artificial Intelligence Solutions for Understanding and Treatment of Neurodegenerative Disorders.

Key Points: 
  • INDRC, International Neurodegenerative Disorders Research Center , a private, non-profit, global research institute established to apply artificial intelligence (AI) and machine learning (ML) solutions to identify and validate therapeutic interventions for Alzheimers disease (AD) and other neurodegenerative disorders, today announced the launch of the INDRC Conference 2022: Artificial Intelligence Solutions for Understanding and Treatment of Neurodegenerative Disorders.
  • The conference will be held on September 7 and 8, 2022, in Prague, Czech Republic, under the auspices of the Czech Ministry for EU Affairs.
  • The INDRC was established to address the challenges facing the identification and validation of new interventions for neurodegenerative disorders.
  • The INDRC, International Neurodegenerative Disorders Research Center , is a private, non-profit, global research institute based in Prague, Czech Republic, that for the first time combines biological sciences and medicine with big data and artificial intelligence approaches to study and treat Alzheimers disease and other neurodegenerative disorders.